Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice.

[1]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[2]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[3]  K. Reynolds,et al.  Cytomegalovirus-specific IFNgamma and IL-4 are produced by antigen expanded human blood lymphocytes from seropositive volunteers. , 1998, Immunology letters.

[4]  L. Campbell,et al.  Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? , 1998, Molecular medicine today.

[5]  B. Metzler,et al.  The role of (auto-) immunity in atherogenesis. , 1998, Wiener klinische Wochenschrift.

[6]  P. Libby,et al.  CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.

[7]  H. Miller,et al.  High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. , 1998, The American journal of cardiology.

[8]  G. Byrne,et al.  Induction of macrophage foam cell formation by Chlamydia pneumoniae. , 1998, The Journal of infectious diseases.

[9]  A. C. Nicholson,et al.  Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Nieminen,et al.  Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[12]  I. Fong,et al.  Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.

[13]  J. Westwick,et al.  Human cytomegalovirus infection up‐regulates interleukin‐8 gene expression and stimulates neutrophil transendothelial migration , 1997, Immunology.

[14]  P. Libby,et al.  Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. , 1997, The Journal of clinical investigation.

[15]  K. Matsushima,et al.  Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene , 1997, Journal of virology.

[16]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[17]  J. Hoekstra,et al.  Patients with diabetes mellitus and atherosclerosis; a role for cytomegalovirus? , 1997, Diabetes research and clinical practice.

[18]  Y. Kaneda,et al.  The Immediate Early Gene of Human Cytomegalovirus Stimulates Vascular Smooth Muscle Cell Proliferationin Vitroandin Vivo , 1997 .

[19]  S. Michelson.  Interaction of human cytomegalovirus with monocytes/macrophages: a love-hate relationship. , 1997, Pathologie-biologie.

[20]  V. Ferrans,et al.  Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. , 1996, Circulation research.

[21]  S. Epstein,et al.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. , 1996, The Journal of clinical investigation.

[22]  J. Grundy,et al.  Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. , 1996, Transplantation.

[23]  P. Sorlie,et al.  Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.

[24]  M. Leon,et al.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1996, The New England journal of medicine.

[25]  M. V. van Dam-Mieras,et al.  Cytomegalovirus infection and vessel wall pathology. , 1996, Intervirology.

[26]  J. Breslow.  Mouse Models of Atherosclerosis , 1996, Science.

[27]  G. Kou,et al.  Human Cytomegalovirus Immediate-Early Protein IE2 Tethers a Transcriptional Repression Domain to p53 (*) , 1996, The Journal of Biological Chemistry.

[28]  C. Dangler,et al.  Murine Cytomegalovirus-associated Arteritis , 1995, Veterinary pathology.

[29]  H. Kamiya,et al.  Increased Expression of Adhesion Molecules (CD54, CD29 and CD44) on Fibroblasts Infected with Cytomegalovirus , 1995, Microbiology and immunology.

[30]  M. Leon,et al.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.

[31]  M. Debakey,et al.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.

[32]  A. Folsom,et al.  Cytomegalovirus/herpesvirus and carotid atherosclerosis: The aric study , 1994, Journal of medical virology.

[33]  M. Debakey,et al.  Cytomegalovirus and atherosclerosis. , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  P. Frederik,et al.  CMV induced vascular injury: an electron-microscopic study in the rat. , 1993, In vivo.

[35]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[36]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[37]  C. V. van Boven,et al.  Cytomegalovirus infection induces vascular injury in the rat. , 1992, Atherosclerosis.

[38]  T. Rector,et al.  Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. , 1989, The American journal of cardiology.

[39]  V. Starnes,et al.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.

[40]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[41]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[42]  K. Bailey,et al.  HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS , 1987, The Lancet.

[43]  B. Paigen,et al.  Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. , 1987, Atherosclerosis.

[44]  B. Paigen,et al.  Variation in susceptibility to atherosclerosis among inbred strains of mice. , 1985, Atherosclerosis.

[45]  M. Debakey,et al.  CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.

[46]  C. Minick,et al.  Brief Definitive Report , 2003 .

[47]  É. Gönczöl,et al.  Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. , 1998, Cell adhesion and communication.

[48]  H. Kamiya,et al.  Changes of adhesion molecule (LFA-1, ICAM-1) expression on memory T cells activated with cytomegalovirus antigen. , 1995, Cellular immunology.

[49]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[50]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  C. V. van Boven,et al.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. , 1990, The American journal of pathology.

[52]  A. Robertson,et al.  Herpesviridae in the coronary arteries and aorta of young trauma victims. , 1988, The American journal of pathology.

[53]  D. Hajjar,et al.  Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. , 1986, The American journal of pathology.